Dec 9, 2022, 10:43 AM by

Nasdaq First North-listed Qlucore, a leading provider of visualization-based software for research and companion diagnostics, will play an important role as one of five key partners in the OmegaPerMed project. The project aims to optimize treatment with omega-3 to prevent cardiovascular diseases (CVD).

Dec 9, 2022, 01:00 AM by User Not Found

Bio-IT World | Advances in mass spectrometry, ultra-high performance liquid chromatography, and bioinformatics have transformed proteomics research in recent years. The growing power of these technologies has contributed to the widespread application of bottom-up proteomics strategies, based on the characterization of proteins by analysis of peptides released through proteolytic digestion. However, challenges in proteomics data analysis remain, with traditional search strategies limiting the ability to fully interpret data.

Dec 8, 2022, 10:04 AM by

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis.

Dec 8, 2022, 10:02 AM by

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations London, UK and Durham, NC – 08 December, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.

Dec 8, 2022, 09:47 AM by

Partnership seeks to increase clinical trials access, accelerate recruitment, and advance ophthalmic research

Dec 8, 2022, 01:00 AM by User Not Found

Bio-IT World | Last month at the Bio-IT World Conference & Expo Europe, Alexandra Grebe de Barron, senior data product owner, digital transformation & IT, introduced the audience to Bayer’s Real-World Data Store, a human- and machine-friendly self-service shop that facilitates real-world evidence generation across the life-long patient pathway.

Dec 7, 2022, 09:44 AM by

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.

Dec 7, 2022, 09:41 AM by

Cinchy was rated ‘best product vision’ in the Forrester Wave for Enterprise Data Fabric, receiving the highest score in that category. The company is on a mission to simplify the way the world works with data. It streamlines the way data’s managed, accessed and used by organizations, and enables them to regain control while collaborating securely in real-time through a single network of interconnected data. It pioneers dataware, a new technology category that can be thought of as the next tech revolution following hardware and software. This essentially frees data from applications – a major advance and breakaway from a 40-year technology norm that required data to be integrated with each new application a company builds, taking up to half of entire IT budgets. See more in the announcement: https://cinchy.com/news/cinchy-scores-5/5-for-product-vision-criterion-in-major-enterprise-data-fabric-report and please let me know if I can provide anything further. Thanks, Amanda Schweitzer amanda@cdc.agency (845) 453-0026

Dec 7, 2022, 09:38 AM by

Global contract development and manufacturing organization (CDMO) Recipharm, today announced an extension of the ongoing commercial manufacturing of RedHill Biopharma’s (Nasdaq: RDHL) drug, Talicia® for the treatment of H. pylori infection, to 2026.

Dec 7, 2022, 09:25 AM by

With the UK’s health system under pressure, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event.

Dec 6, 2022, 11:33 AM by

Dec 6, 2022, 11:32 AM by

MultiOmic Health, an artificial intelligence-enabled precision medicine discovery company, today announces the signing of a research collaboration agreement with Northern Care Alliance (NCA) NHS Foundation Trust in Manchester, England.

Dec 6, 2022, 11:31 AM by

LogicStream Health and FDB Collaborate to Help Improve Management of Drug Shortages . LogicStream’s Drug Supply App™ now recommends therapeutic alternatives to minimize impact of drug supply disruptions

Dec 6, 2022, 11:29 AM by

Dec 6, 2022, 01:00 AM by User Not Found

Bio-IT World | Truly implementing precision medicine requires that environmental exposures be factored into the equation. Mayo Clinic’s recent Individualizing Medicine Conference focused on exploring the exposome, the sum of external factors a person is exposed to across a lifetime.

Dec 5, 2022, 10:51 AM by

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E funding round. This demonstrates the heightened interest and growing demand for new treatments for Dry Eye Disease (DED).

Dec 5, 2022, 10:50 AM by

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, has awarded a $100,000 research grant to Andy Livingston, M.D., a clinician and researcher in Sarcoma Medical Oncology and in Pediatric Oncology at The University of Texas MD Anderson Cancer Center. Ann Graham, Founder and Executive Director of MIB Agents, and Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Livingston on Dec. 1 in Houston.

Dec 2, 2022, 10:38 AM by

This latest product is an innovative power and data management system that reduces risk and accelerates cleanroom delivery for the life sciences and pharmaceutical industry.

Dec 2, 2022, 10:37 AM by

Dec 2, 2022, 10:36 AM by

Quotient Sciences, a global drug development and manufacturing accelerator, today announced a partnership with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.